ArticleMolecular oncology2022

FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.

Christopher I Milton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.